Skip to main content
CPBLF logo

ALS Limited (CPBLF) Stock: Price, Forecast & Analyst Target

ALS Limited (CPBLF) — price $14.41 (0.00%), as of the Nov 18, 2026 trading session; market cap $8.24B.

Educational signal · not a buy or sell recommendation · How to read this

$14.41 $0.00 (0.00%) Market Cap $8.24B

ALS Limited · CPBLF

ALS Limited is a global provider of professional technical services, specializing in testing, measurement, and inspection across Life Sciences, Commodities, and Industrial sectors. Headquartered in Australia, the company serves diverse markets from environmental analysis to mining and infrastructure projects worldwide.

Price as of Nov 18, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • BAH · Booz Allen Hamilton Holding Corporation · 77 /100
  • FCN · FTI Consulting, Inc. · 85 /100
  • TRU · TransUnion · 73 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$14.41
Change on the day0.00%
52-week range$10.95 – $18.19
Market capitalisation$8.24B—
Price / earnings (trailing)32.78
Shares traded on the day161

Price & events

Other perspectives

Council score for ALS (CPBLF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Neutral
Revenue Growth Moderate
Debt/Equity Weak
ROE Moderate
Gross Margin Weak

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is ALS (CPBLF), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. ALS Limited (CPBLF) is the company analyzed here. It employs 23,342 people and is led by Malcolm Deane. In Q4 FY2026 it reported revenue of A$1.66B and net income of A$177M. The market values it at $8.24B.

2 · Latest results

What do the latest results show for ALS (CPBLF)?

Short answer · as of

The most recent reported quarter, Q4 FY2026, carried revenue of A$1.66B. Against analyst estimates the company has EPS beat 6 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2026A$1.66BA$177MA$0.35 (diluted)
Q2 FY2026A$1.66BA$142MA$0.29 (diluted)
Q4 FY2025A$1.54BA$129MA$0.27 (diluted)
Q2 FY2025A$1.46BA$127MA$0.26 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for ALS (CPBLF)?

Short answer · as of

The distress and quality screens read Altman Z 4.27 · Piotroski F 6. Trailing ratios: ROE 18.9% · ROA 8.0% · current ratio 1.47 · earnings yield 2.9% · free-cash-flow yield 2.1%.

4 · What to check next?

What should you watch next at ALS (CPBLF)?

Short answer · as of

Current published price targets run low $28.00 · high $28.00 · consensus $28.00 · median $28.00 against a quoted price of $14.41 (as of Nov 18, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • No insider Form 4 transaction falls inside the window this page reads.
  • Fewer than two score snapshots exist, so no score trend is shown.

Checked against the records this page reads, on the dates shown above.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$28.00 – $28.00
Consensus target
$28.00
Median target
$28.00

Consensus record · Captured .

Measured against a quoted price of $14.41 (as of Nov 18, 2026).

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CPBLF in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported CPBLF in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about ALS (CPBLF)?

Read these with our analysis →

What Investors Ask About ALS (CPBLF)

These answers are editorial: 1 of these 8 answers is drawn from the CPBLF research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is CPBLF a good stock to buy?

Stock Expert AI does not rate CPBLF buy, sell or hold. ALS Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the CPBLF stock price today?

The last price recorded for ALS Limited (CPBLF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the CPBLF price target?

The analyst consensus price target for ALS Limited (CPBLF), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What does ALS Limited do?

ALS Limited provides professional technical services globally, specializing in testing, measurement, and inspection. Its operations are divided into three segments: Life Sciences, Commodities, and Industrial.

What are the key factors to evaluate for CPBLF?

Evaluate CPBLF on fundamentals, analyst consensus, and risk factors. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Expansion in Life Sciences Environmental Testing: The global demand for environmental analytical testing is projected to grow significantly, driven by increasing regulatory scrutiny, public awareness of climate change, and industrial pollution concerns. Not financial advice.

How frequently does CPBLF data refresh on this page?

CPBLF's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven CPBLF's recent stock price performance?

ALS Limited (CPBLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global presence across Africa, Asia/Pacific, Europe, Middle East, North Africa, and the Americas. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CPBLF overvalued or undervalued right now?

The trailing P/E of ALS Limited (CPBLF) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 19 figures on this page — 12 from Financial Modeling Prep (FMP) and 7 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.